2
Total deals
$137.5M
Total value
$68.8M
Avg deal
$125.0M
Largest
| # | Acquired | Date | Type | Status | Price | |
|---|---|---|---|---|---|---|
| 1 |
Atreca
Atreca develops a technology to identify the set of antibodies produced during a…
|
2023-12-26 | Acquisition | Complete | $12.5M | Deal → |
| 2 |
MorphImmune
MorphImmune is a preclinical biotechnology company that targets small-molecule t…
|
2023-06-29 | Merge | Complete | $125.0M | Deal → |